Uncategorised - European Medical Journal

England Relaunches Women’s Health Strategy Amid “Medical Misogyny”

The UK Government has relaunched the Women’s Health Strategy for England on 14th April 2026, following select committee findings of “medical misogyny” in the NHS.

Tuberculosis Vaccine Trial Shows Limited Overall Protection

A phase 3 trial of two tuberculosis vaccines shows limited overall protection but meaningful efficacy against extrapulmonary disease in selected groups.

Dr Henar Hevia on navy blue background

Dr Henar Hevia talks to data, decision-making and cancer care

Columnist Dr Henar Hevia, J&J Innovative Medicine, explores how oncology’s future hinges on smarter use of data.

England’s Advances Towards Hepatitis C Elimination Targets

England reports progress towards hepatitis C elimination as prevalence falls, with diagnosis gaps and harm reduction challenges remaining.

Primary care consultation illustrating health care barriers and cancer screening access.

Health Care Barriers Cut Cancer Screening

Health care barriers were linked to lower cancer screening adherence across five major cancer types.

High-Resolution MRI Improves Brain Imaging Clarity

5.0 T SWI improves brain imaging clarity compared with 3.0 T, enhancing visualisation of cerebral veins and deep grey matter structures in healthy adults.

Clinician reviewing treatment options for depression and obsessive-compulsive disorder with focus on parenteral clomipramine

Clomipramine Findings Raise Ketamine Research Questions

Parenteral clomipramine showed no clear early advantage over oral therapy for depression, while evidence in OCD remained limited.

15 Apr 2026

Entering a New Era in Protection in Haemophilia A

Haemophilia A (HA), defined by factor VIII (FVIII) levels ≤40 IU/dL, is a chronic condition with consequences beyond bleeding…

Illustration showing the relationship between the gut microbiome and vascular health

How the Gut Microbiome Shapes Atherosclerosis Risk

Gut microbiome shifts may help drive atherosclerosis and peripheral artery disease through inflammatory and metabolic pathways.

ischaemic heart disease

Poor Diet Drives Global Ischaemic Heart Disease Burden

New findings from the Global Burden of Disease 2023 analysis showed that dietary risks were responsible for an estimated 4.06 million IHD deaths and 96.84 million disability-adjusted life years in 2023.